Fairtility, the transparent AI innovator advancing in vitro fertilization (IVF) for improved outcomes, announced today that Chief Strategy Officer, Yael Kfir, has joined the Artificial Intelligence Fertility Society (AIFS) as Co-Chair of the Regulatory Subcommittee will function.
AIFS was established following the first AI Fertility Conference in Dubrovnik, Croatia in September 2022 with a mission to advocate and guide the fertility field in the development of AI, big data systems and future technologies to improve assisted reproductive care. The regulatory subcommittee will provide professional leadership on the development and regulation of AI in fertility to improve the safety, efficacy and efficiency of AI innovations with the aim of increasing treatment access and success through an open and collaborative dialogue with regulators to maximize.
“As an industry, we have a shared vision, and institutions large and small are working together to introduce AI solutions to the IVF care paradigm and improve treatment outcomes,” said Yael Kfir, Fairtility’s Chief Strategy Officer. “As the first of its kind, AIFS recognizes the importance and responsibility of working closely with regulators to define how best to ensure leading AI-based decision support systems meet agreed standards when they go to market. With these actions, AI-Powered IVF systems will gain the trust of physicians and regulators and be integrated into daily clinical practice to improve the outcome of IVF patient care.”
Yael Kfir serves as Fairtility’s Chief Strategy Officer and brings 25 years of senior management experience in healthcare and pharmacy with a particular focus on the IVF space, its key stakeholders and an understanding of the regulatory landscape. Fairtility joined the new association as an early financial supporter and Kfir took a leading role in developing the agenda for the AI Fertility Society and helping to define key areas of common interest among members. The organization is multidisciplinary in structure and includes healthcare providers, patient advocates, academics, product developers, psychologists, data scientists, mathematicians, entrepreneurs, and governments and regulators.
